TirzepatideIllustrative mockup✱ Metabolic Health · Weight Management
Tirzepatide
A dual GIP and GLP-1 receptor agonist used in FDA-approved prescription medicines for specific indications.
Specification
Code
TR10
Per vial
$149.00
Kit (10 vials)
$1,490.00
Illustrative, nonbinding reference price. No payment is collected. Prescription products require licensed-clinician review.
FDA-approved prescription medicine (branded). Tirzepatide is the active ingredient in FDA-approved branded medicines (Mounjaro® for type 2 diabetes; Zepbound® for chronic weight management and obstructive sleep apnea in adults with obesity). The vial strengths listed here are catalog references and are not FDA-approved branded presentations. Any request requires licensed-clinician review and lawful pharmacy fulfillment.
✱ Overview
What is Tirzepatide?
Tirzepatide is a once-weekly injectable medicine that activates two incretin hormone receptors: glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1).
It is FDA-approved in branded products for specific indications in specific patients. Compounded or otherwise unapproved preparations are not the same as FDA-approved products and have not undergone the same review.
✱ Mechanism
How it works
GLP-1 and GIP receptor activation increases glucose-dependent insulin secretion, reduces glucagon, slows gastric emptying and acts on brain regions that regulate appetite and satiety.
The result is reduced food intake and improved blood-glucose control, which in large trials translated into clinically meaningful weight loss.
✱ Key research areas
What the science says — and how sure it is.
01
Glucose regulation
Established clinical evidence
Phase 3 SURPASS trials showed HbA1c reduction in type 2 diabetes, supporting FDA approval.
02
Weight-management research
Established clinical evidence
SURMOUNT trials showed substantial weight reduction in adults with obesity, supporting FDA approval.
03
Appetite, satiety & gastric emptying
Established clinical evidence
Reduced appetite, earlier fullness and slowed gastric emptying are well-documented effects.
04
Obstructive sleep apnea
Established clinical evidence
Approved for moderate-to-severe OSA in adults with obesity based on SURMOUNT-OSA.
05
Cardiovascular outcomes
Preliminary findings
Outcome trials are ongoing.
✱ Available specifications
Catalog reference
| Code | Specification | Vials / kit | Ref. price / vial | Kit total (calc.) |
|---|---|---|---|---|
| TR10 | 10 mg/vial | 10 | $149.00 | $1,490.00 |
| TR20 | 20 mg/vial | 10 | $199.00 | $1,990.00 |
Prices are editable, illustrative per-vial references — not verified supplier costs or selling prices. Kit total = per-vial price × vials per kit.
✱ Inquiry process
What happens next
01
Request
Choose a specification and quantity. See an itemized estimate.
02
Review
Our team reviews your request and may ask follow-up questions.
03
Professional pathway
Any prescription requires a licensed clinician and lawful pharmacy. A quote is never a prescription.
✱ Evidence & safety
Read before you ask.
Evidence quality: High for approved branded products in approved indications.
Regulatory status: FDA-approved prescription medicine (branded)
Known safety concerns
- Nausea, diarrhea, vomiting, constipation
- Risk of pancreatitis and gallbladder disease
- Hypoglycemia with insulin or sulfonylureas
- Boxed warning: thyroid C-cell tumors in rodents
- May reduce effectiveness of oral contraceptives
Contraindications & cautions
- Personal or family history of medullary thyroid carcinoma
- Multiple endocrine neoplasia syndrome type 2 (MEN 2)
- Known serious hypersensitivity to tirzepatide
- Pregnancy
This information is educational and incomplete. Always seek advice from a qualified medical professional.
✱ FAQ
Tirzepatide questions
No. Those are FDA-approved branded products. The catalog vials listed here are reference listings, not branded presentations.
Yes. Tirzepatide requires evaluation and a prescription from a licensed clinician, and lawful pharmacy fulfillment.
No. A quote request is not a prescription, medical approval or purchase.
✱ Related
You may also want to read about
Lipo-C + B12✱ Metabolic Health
Lipo-C + B12
A lipotropic and vitamin B12 formulation explored for its role in fat metabolism and cellular energy pathways.
Retatrutide✱ Metabolic Research
Retatrutide
An investigational triple-receptor agonist acting on GIP, GLP-1 and glucagon receptors.